| 37.00 |  0.00 / 0.00% |
Data as of 4:00pm ET | Day’s Change |
| 37.01 |  +0.0074 / +0.02% |
Volume: 1.5K |
| Top Insider Trades: DXM, SPB, AMTD, GHDX May 17 / TheStreet.com | Genomic Gains Coverage for DCIS - Analyst Blog May 13 / Zacks.com |
| Much Awaited Test Launch by Genomic - Analyst Blog May 15 / Zacks.com | GHDX Reports Loss, Beats on Revs - Analyst Blog May 13 / Zacks.com |
| Previous close | 37.00 |
| Today’s open | 36.84 |
| Day’s range | 36.75 - 37.11 |
| Volume | 163,918 |
| Average volume (3 months) | 221,130 |
| Market cap | $1.1B |
| Dividend yield | -- |
| Earnings growth (last year) | 0.00% |
| Earnings growth (this year) | -117.67% |
| Earnings growth (next 5 years) | +24.40% |
| Revenue growth (last year) | +14.10% |
| P/E ratio | 185.0 |
| Price/Sales | 3.51 |
| Price/Book | 8.77 |
| Today’s change | Today’s % change | |
|---|---|---|
| NEOGNeogen Corp | +0.09 | +0.16% |
| VIVOMeridian Bioscience ... | +0.23 | +1.06% |
| QDELQuidel Corp | +0.52 | +2.35% |
| DNDNDendreon Corp | -0.02 | -0.51% |
| Next reporting date | August 7, 2013 |
| EPS forecast (this quarter) | -$0.08 |
| Annual revenue (last year) | $235.2M |
| Annual profit (last year) | $8.2M |
| Net profit margin | 3.51% |
Sector Health Technology |
Industry Biotechnology |
Chairman, President & Chief Executive Officer Kimberly J. Popovits |
Chief Operating Officer G. Bradley Cole, MBA |
Corporate headquarters Redwood City, California |
.
